Cite
MLA Citation
M Fumery et al.. “P638 Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: a GETAID multicentre cohort study.” Journal of Crohn's and colitis, vol. 17, n.d., p. i770. http://access.bl.uk/ark:/81055/vdc_100179843796.0x000008